THE IDENTIFICATION AND VALIDATION OF EPITOPES CONSERVED IN VIRAL PATHOGEN FAMILIES WITH PANDEMIC POTENTIAL
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 75N93024C00056-0-9999-1
Grant search
Key facts
Disease
Lassa Haemorrhagic Fever, COVID-19…Start & end year
20242025Known Financial Commitments (USD)
$1,124,982Funder
National Institutes of Health (NIH)Principal Investigator
BRANDON FABRITZKYResearch Location
United States of AmericaLead Research Institution
LA JOLLA INSTITUTE FOR IMMUNOLOGYResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This contract will identify and validate epitopes conserved in viral pathogen families with pandemic potential in accordance with NIAID's Pandemic Preparedness Plan. Accordingly, for each viral family we select a prototype virus that will be utilized in the epitope identification screen. The viral families and prototype viruses included are: Coronaviridae (SARSCoV- 2), Flaviviridae (DENV2), Togaviridae (CHIKV)), Paramyxoviridae (Measles), Arenaviridae (Lassa), and Picornaviridae (Poliovirus).